Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | BRD-K27224038 | CTRPv2 | pan-cancer | AAC | 0.034 | 0.7 |
mRNA | dabrafenib | CTRPv2 | pan-cancer | AAC | -0.02 | 0.7 |
mRNA | Gemcitabine | GDSC1000 | pan-cancer | AAC | -0.014 | 0.7 |
mRNA | BRD-K86535717 | CTRPv2 | pan-cancer | AAC | -0.029 | 0.7 |
mRNA | BI-2536 | FIMM | pan-cancer | AAC | -0.047 | 0.7 |
mRNA | BRD-K79669418 | CTRPv2 | pan-cancer | AAC | 0.021 | 0.7 |
mRNA | fulvestrant | CTRPv2 | pan-cancer | AAC | 0.03 | 0.7 |
mRNA | Bexarotene | FIMM | pan-cancer | AAC | 0.054 | 0.7 |
mRNA | MK-2206 | GDSC1000 | pan-cancer | AAC | -0.014 | 0.7 |
mRNA | Cyclopamine | FIMM | pan-cancer | AAC | 0.051 | 0.7 |